|
Q2 FY2026
As of Jun 28, 2026
|
Q1 FY2026
As of Mar 29, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 28, 2025
|
Q2 FY2025
As of Jun 29, 2025
|
Q1 FY2025
As of Mar 30, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Oct 1, 2023
|
Q2 FY2023
As of Jul 2, 2023
|
Q1 FY2023
As of Apr 2, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Oct 2, 2022
|
Q2 FY2022
As of Jul 30, 2022
|
Q1 FY2022
As of Apr 3, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 26, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, less allowance for credit losses of $2,086 and $1,856, respectively | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaids and other current assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles assets, net | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net of current portion | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Earn-out liability | ||||||||||||||||||||
| Deferred taxes | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, $0.0001 par value, 5,000,000 shares authorized, none issued and outstanding on June 28, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, $0.0001 par value, 550,000,000 shares authorized, 120,847,506 and 119,670,987 shares issued on June 28, 2026 and December 31, 2025; and 120,140,393 and 119,670,987 shares outstanding on June 28, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
